Can Chinese Phase I data from the West accelerate China drug development?
The science of ethnobridging – a way to implement cost-effective, multi-ethnic approaches to global clinical trial research and drug development.
Related Insights
Video
The science and practice of ethnobridging
May 17, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Australia: A highly attractive environment for drug development
Aug 24, 2023
Blog
To build a state-of-the-art oncology site network, we went back to basics
Mar 3, 2025
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Article
Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?
Jun 30, 2021
Article
India, the Generic Manufacturing Powerhouse, Biosimilar Next?
Jul 21, 2021
Article
Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?
Aug 6, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Blog
CNS Summit Recap: The Future is Collaborative
Nov 22, 2021
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Related Insights
Video
The science and practice of ethnobridging
May 17, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Australia: A highly attractive environment for drug development
Aug 24, 2023
Blog
To build a state-of-the-art oncology site network, we went back to basics
Mar 3, 2025
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Article
Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?
Jun 30, 2021
Article
India, the Generic Manufacturing Powerhouse, Biosimilar Next?
Jul 21, 2021
Article
Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?
Aug 6, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Blog
CNS Summit Recap: The Future is Collaborative
Nov 22, 2021
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022